Fig. 7
From: Long non-coding RNA SOX2OT in tamoxifen-resistant breast cancer
Expression of SOX2OT in patients with breast cancer according to the various subtypes of breast cancer. The expression of SOX2OT was highest in luminal type of breast cancer, and it was lower in TAMR breast cancer than in luminal B type and triple-negative breast cancer